Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

NCT01944735 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: CTX-4430
DRUG: Placebo

Sponsor

Celtaxsys, Inc.

Collaborators

[object Object]